Skip to main content

OHI Omega Healthcare Investors, Inc.

Real Estate

47.00 +0.02 +0.05% Close 11/2
Since 2024-12-02 +32.0%
Open
46.93
High
47.39
Low
46.70
Prev close
46.98
Volume
2.1M
Amplitude
1.47%
P/E
16.8
P/B
2.6
Revenue YoY (TTM)
+15.9%
52W 40.86 52.39

Is Omega Healthcare Investors, Inc. a buy? Fundamentals and valuation first

As of 2026-10-30

Valuation: Fair, Quality: Strong, Growth: Good, Momentum: Good, Risk / liquidity: Strong.

Valuation Fair Free-cash-flow yield is Good, but Price / book is Pricey.
TTM P/E 16.78 46th percentile Fair
Price / book 2.64 68th percentile Pricey
Free-cash-flow yield (%) 6.35 72th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Strong FCF margin, TTM is Top; ROE, TTM is Good.
ROE, TTM (%) 15.92 77th percentile Good
Operating margin, TTM (%) 62.39 94th percentile Top
FCF margin, TTM (%) 69.92 95th percentile Top
Quality Factor Investing: A US Quality Value Backtest
Growth Good Diluted EPS growth, TTM YoY is Top; Revenue growth, TTM YoY is Good.
Revenue growth, TTM YoY (%) 15.91 70th percentile Good
Diluted EPS growth, TTM YoY (%) 72.84 81th percentile Top
Momentum Good All 2 indicators are Good.
60-day return (%) -3.49 58th percentile Good
240-day return (%) 11.54 64th percentile Good
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Strong 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 88,846,888 86th percentile Top
60-day annualized volatility (%) 21.14 23th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Omega Healthcare Investors, Inc. (OHI) today

1 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Omega Healthcare Investors, Inc. to every stock like it

AI finds several complementary traits of Omega Healthcare Investors, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Omega Healthcare Investors, Inc.

Omega Healthcare Investors, Inc. (OHI) peers and tracking

Watchlist

This page refreshes daily after the close. Add Omega Healthcare Investors, Inc. to your watchlist to track signal changes on your next visit.

Omega Healthcare Investors, Inc. (OHI) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Filed revenue acceleration

Active · now 15.91%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

8 historical occurrences (since 2020-08-07)

Average forward return after Filed revenue acceleration

20-day: Win 50%, Sample 8, Median -0.41%, Excess -3.69%, Beat mkt rate 25%

60-day: Win 62.5%, Sample 8, Median +2.81%, Excess -3.27%, Beat mkt rate 37.5%

120-day: Win 71.4%, Sample 7, Median +11.47%, Excess +1.41%, Beat mkt rate 57.1%

120 days after: historical avg +8.04%

20-day -0.36%
60-day +1.61%
120-day +8.04%
20-day
60-day
120-day
Win
50%
62.5%
71.4%
Sample
8
8
7
Median
-0.41%
+2.81%
+11.47%
Excess
-3.69%
-3.27%
+1.41%
Beat mkt rate
25%
37.5%
57.1%

Over 7 occurrences, 120-day forward avg gained 8.04%, beat the market by 1.41 pts; win rate 71.4%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 You are here291+17.8% +15.8% 94.2% +8.7%
20-40 410+22.1% +21.6% 97.8% -0.1%
40-60 241+17.5% +16.9% 96.7% +3.9%
60-80 377+16.7% +19.1% 80.6% +4.5%
80-100 124-13.8% -15.4% 3.2% -32.6%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 16.78, placing it in the 19.1 own-history percentile, inside the 0-20 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+9.1%
Win rate 67.7% Excess +5.9%
257d
+11.2%
Win rate 78.6% Excess +2.7%
509d
-3.1%
Win rate 43.7% Excess -15.7%
245d
60-day momentum down
Now
+15%
Win rate 89.2% Excess +7.3%
286d
+9.2%
Win rate 69.1% Excess +2.7%
194d
-6.7%
Win rate 27.8% Excess -15.4%
72d

Currently in “Cheap (own-history bottom third) × 60-day momentum down”: across 286 historical days, 120-day forward avg gained 15%, win rate 89.2%, beat the market by 7.3%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

19 times historically; 60-day forward avg +1.33%, win rate 63.2%, beating the market by -1.06 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest

14 times historically; 60-day forward avg +4.17%, win rate 78.6%, beating the market by +3.97 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

10 times historically; 60-day forward avg +4.52%, win rate 60%, beating the market by +2.61 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.